Symphony Financial’s Labcorp LH Stock Holding History

Symphony Financial’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,131	Closed	-$525K	–	183
2021 Q3	$525K	Buy	+2,131	New	+$537K	0.18%	93

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Symphony Financial's LH Position: Q4 2021 in Review

Symphony Financial sold out of Labcorp (LH) in Q4 2021, closing a stake of 2,131 shares — an estimated $525K sold.

Symphony Financial first reported a position in LH in Q3 2021 and held it in 1 quarter. The position peaked at $525K in Q3 2021. 1,061 funds tracked by Wall St. Rank hold LH as of Q4 2021.

Symphony Financial reported no remaining Labcorp position as of Q4 2021 after selling out during the quarter.
Symphony Financial sold 2,131 Labcorp shares in Q4 2021, an estimated $525K.
Symphony Financial first reported a position in Labcorp in Q3 2021 and held it in 1 quarter.
Symphony Financial's Labcorp position peaked at $525K in Q3 2021.
1,061 funds tracked by Wall St. Rank held Labcorp as of Q4 2021.

Based on Symphony Financial's 13F filing for Q4 2021, filed 19 Jan 2022.